Blog

July 27, 2017

Update1

KDL now providing FDA-approved BRAF testing for all metastatic melanomas.
July 27, 2017

News 2

Cancer survivors may be at higher risk of developing Melanoma.
July 27, 2017

News 1

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma.